Cellatoz Therapeutics is Biotechnology in South Korea that focus on regenerative medicine business. Founded in 2017. They cover business area such as developer, regenerative medicine advanced therapy, intractable disease, differentiated therapeutic cell technology, cell therapy product, its intermediary research and product development capability, patient, musculoskeletal-relate disease, regeneration, tissue.
2017
( 7 years old in 2024 )
Regenerative Medicine
-
17, Pangyo-ro 228beon-gil, Bundang-gu
Seongnam-si, Gyeonggi-do
South Korea
Private
developerregenerative medicine advanced therapyintractable diseasedifferentiated therapeutic cell technologycell therapy productits intermediary research and product development capabilitypatientmusculoskeletal-relate diseaseregenerationtissue
* We use standard office opening hours in near Cellatoz Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cellatoz Therapeutics is Biotechnology business from South Korea that founded in 2017 (7 years old in 2024), Cellatoz Therapeutics business is focusing on Regenerative Medicine.
Cellatoz Therapeutics headquarter office and corporate office address is located in 17, Pangyo-ro 228beon-gil, Bundang-gu Seongnam-si, Gyeonggi-do South Korea.
Cellatoz Therapeutics was founded in South Korea.
In 2024, Cellatoz Therapeutics is currently focus on regenerative medicine sector.
Above is snippet of Google Trends for "regenerative medicine" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cellatoz Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
